Cargando…
Liquid profiling of circulating tumor DNA in colorectal cancer: steps needed to achieve its full clinical value as standard care
The analysis of circulating tumor DNA (ctDNA) is at the threshold of implementation into standard care for colorectal cancer (CRC) patients. However, data about the clinical utility of liquid profiling (LP), its acceptance by clinicians, and its integration into clinical workflows in real‐world sett...
Autores principales: | Hedtke, Maren, Pessoa Rejas, Rodrigo, Froelich, Matthias F., Ast, Volker, Duda, Angelika, Mirbach, Laura, Costina, Victor, Martens, Uwe M., Hofheinz, Ralf‐Dieter, Neumaier, Michael, Haselmann, Verena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120900/ https://www.ncbi.nlm.nih.gov/pubmed/34873826 http://dx.doi.org/10.1002/1878-0261.13156 |
Ejemplares similares
-
Liquid Profiling for Cancer Patient Stratification in Precision Medicine—Current Status and Challenges for Successful Implementation in Standard Care
por: Haselmann, Verena, et al.
Publicado: (2022) -
Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-Syndrome
por: Gerhards, Catharina, et al.
Publicado: (2023) -
Plasma-based S100B testing for management of traumatic brain injury in emergency setting
por: Haselmann, Verena, et al.
Publicado: (2021) -
Exploring the Synergistic Potential of Radiomics and Laboratory Biomarkers for Enhanced Identification of Vulnerable COVID-19 Patients
por: Gerhards, Catharina, et al.
Publicado: (2023) -
Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection
por: Ast, Volker, et al.
Publicado: (2021)